AMP 2013 Annual Meeting
November 14-16, 2013
Phoenix Convention Center
Phoenix, AZ
Corporate Workshop Day
November 13, 2013
Visit Meeting Page

AMP 2013 MGP Review Course
April 4-7, 2013
Double Tree by Hilton Hotel
Bethesda - Washington DC
Visit Course Page

more information

AMP Position Statements and Letters

AMP Position statements and letters

AMP Position Statements and Letters - 2010

2010	Title	Keywords	Committee

October	Comments to the SACGHS re: Whole Genome Sequencing		Whole Genome Analysis Working Group
	Letter to FDA Expressing Concerns Over Potential Medical Device Registration Requirement		Multi-Association Coalition

September	Letter to FDA Encouraging Continued Dialogue re: LDTs		Multi-Association Coalition

July	Comments to NIH regarding the Genetic Test Registry		Professional Relations
	Comments to FDA regarding oversight of laboratory developed tests		Professional Relations

June	Comments to SACGHS regarding the draft report on Genetics Education and Training		Professional Relations
	Comments to FDA regarding regulation of cytogenetic arrays		Arrays Working Group
	Comments to FDA CDRH Council regarding barriers to market for molecular diagnostic tests		Professional Relations
	Comments to SACGHS regarding Whole Genome Sequencing		Clinical Practice

February	Comments to the SACGHS to finalize gene patent report and recommendations as presented in October 2009		Professional Relations

	Comments to AHRQ on the draft Technology Assessment, "Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment"		Professional Relations

January	AMP's position on the oversight of laboratory developed tests (LDTs) released and discussed with FDA		Professional Relations
	AMP presents to MEDCAC regarding pharmacogenomic testing		Professional Relations